No Match Found
Countries are moving towards resolution of the pandemic and attempting to get back to business as usual. It is critical that the senior leadership look beyond crisis management and business continuity towards reimagining profound economic & societal changes and design a program to emerge stronger.
We examine the potential shifts that will impact the Pharmaceutical & Life Sciences Sector and consider the steps industry leaders should take, using our Fit For Rebound framework.
Take a position on the most profound permanent or structural shifts in your geographies, sectors, clients, people, and assess the impact on your organisation and ambitions.
Determine a rough timeline for the economy where you’re operating to move from “Explosive” to "Managing" and "Controlled" state. Then imagine what bold, wise decisions would you want to have taken in anticipation of the new normal?
Establish a "Fit for Rebound" programme to deliver on those decisions. Radically reassess your priorities, organisation, assets, projects, policies, cost base, projections, policies, and culture.
Rise of Asia and shift towards localised decision-making
Healthcare shifts to the patient’s home or community
Greater health data sharing and analytics
Constrained funding/ financing across payors and providers
Focus on supply chain reliability and traceability of key medicines/ equipment
Shifting channel dynamics and digital clinician engagement
Normalisation of remote working practice and a laser-focus on productivity
Regulators encourage data sharing and digital services
Greater R&D focus on infectious disease and vaccines and personalised clinical responses
|Develop an Agile Strategy
|Double Down on Differentiating Post-crisis Capabilities
|Sustain without Sacrificing the Recovery
|Pivot for the New Normal
|Accelerate Cultural Revolution
Insurance and Wealth Leader, South East Asia Consulting, PwC Singapore
Tel: +65 9159 1425
Pharmaceutical & Life Sciences Strategy Leader, South East Asia Consulting, PwC Singapore
Tel: +65 9624 5189
Dr Zubin J Daruwalla
Health Industries Leader, PwC Singapore
Tel: +65 9751 7023